TipRanks
Go Ultimate55% OFF

Jeffrey Mathiesen Insider Profile

4 Followers

Jeffrey Mathiesen, Director at NeuroOne Medical Technologies, holds 156.34K shares in NeuroOne Medical Technologies (Ticker: NMTC), holds 11.95K shares in Solana Company (Ticker: HSDT), holds 10.19K shares in Panbela Therapeutics (Ticker: PBLA).

Jeffrey Mathiesen's Trading History

NMTC
NeuroOne Medical Technologies
Apr 07, 2026DirectorUninformative Buy―$144.93K
HSDT
Solana Company
Feb 18, 2022CFO & Treasurer, DirectorUninformative Buy―$24.97K
PBLA
Panbela Therapeutics
May 27, 2021DirectorUninformative Buy―$112.10
NUWE
Nuwellis
Jan 02, 2015CFOUninformative Sell4.04K$278.88K
HCTI
Healthcare Triangle
―Director――
MTVA
MetaVia
―Chief Financial Officer――

You May Also Like

Jeffrey Mathiesen insider profile FAQ

What is the percentage of profitable transactions made by Jeffrey Mathiesen?
The percentage of profitable transactions made by Jeffrey Mathiesen is 0%.
What is the average return per transaction made by Jeffrey Mathiesen?
The average return per transaction made by Jeffrey Mathiesen is -64.10%.
What stocks does Jeffrey Mathiesen hold?
Jeffrey Mathiesen holds: NMTC, NUWE, HSDT, MTVA, PBLA, HCTI stocks.
What was Jeffrey Mathiesen's most profitable transaction?
Jeffrey Mathiesen’s most profitable transaction was an Informative Buy of NUWE stock on March 17, 2014. The return on the trade was -33.10%.
What is Jeffrey Mathiesen's role in NeuroOne Medical Technologies?
Jeffrey Mathiesen's role in NeuroOne Medical Technologies is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.